Cellular targets and mechanistic strategies of remyelination-promoting IgMs as part of the naturally occurring autoantibody repertoire

Natural autoantibodies in the physiology and pathophysiology of the immune system

(2013) Stratis Avrameas et al.   JOURNAL OF AUTOIMMUNITY

PDGF is Required for Remyelination-Promoting IgM Stimulation of Oligodendrocyte Progenitor Cell Proliferation

(2013) Jens O. Watzlawik et al.   PLoS One

Paraproteinemic neuropathies

(2013) Ricard Rojas-García et al.   PRESSE MEDICALE

High-Affinity Binding of Remyelinating Natural Autoantibodies to Myelin-Mimicking Lipid Bilayers Revealed by Nanohole Surface Plasmon Resonance

(2012) Nathan J. Wittenberg et al.   ANALYTICAL CHEMISTRY

Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease

(2012) Azeb Tadesse Argaw et al.   JOURNAL OF CLINICAL INVESTIGATION

Immunoglobulin secretion by B1 cells: Differential intensity and IRF4-dependence of spontaneous IgM secretion by peritoneal and splenic B1 cells

(2010) Nichol E. Holodick et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Human remyelination promoting antibody inhibits apoptotic signaling and differentiation through Lyn kinase in primary rat oligodendrocytes

(2010) J. Watzlawik et al.   GLIA

Developmental stage-dependent expression of an  2,8-trisialic acid unit on glycoproteins in mouse brain

(2010) E. Inoko et al.   GLYCOBIOLOGY

The effects of blood–brain barrier disruption on glial cell function in multiple sclerosis: Figure 1

(2009) Stephen McQuaid et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Somatic hypermutation in peritoneal B1b cells

(2009) Bishnudeo Roy et al.   MOLECULAR IMMUNOLOGY

Natural antibodies and cancer

(2009) H. Peter Vollmers et al.   New Biotechnology

A new tumor-specific variant of GRP78 as target for antibody-based therapy

(2008) Nicole Rauschert et al.   LABORATORY INVESTIGATION